42656 Federal Register / Vol. 83, No. 164 / Thursday, August 23, 2018 / Notices 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

RFA–CE19–001, Injury Control Research 

Centers. 

Dates: October 30, 2018 and 

November 2, 2018 

Time: 8:30 a.m.–5:00 p.m., EDT 

Place: The Georgian Terrace, 659 

Peachtree St. NE, Atlanta, GA, 30308 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Mikel L. Walters, M.A., Ph.D., Scientific 

Review Official, NCIPC, CDC, 4770 

Buford Highway NE, Mailstop F–63, 

Atlanta, Georgia 30341, Telephone: 

(404) 639–0913; Email: mwalters@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–18188 Filed 8–22–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Advisory Committee on 

Immunization Practices 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

of the Advisory Committee on 

Immunization Practices (ACIP). This 

meeting is open to the public, limited 

only by room seating. The meeting room 

accommodates 400. Time will be 

available for public comment. 

DATES: The meeting will be held on 

October 24, 2018, 8:30 a.m. to 5:15 p.m., 

EDT, and October 25, 2018, 8:30 a.m. to 

4:00 p.m. EDT. 

The public is welcome to submit 

written comments in advance of the 

meeting. Comments should be 

submitted in writing by email to the 

contact person listed in FOR FURTHER

INFORMATION CONTACT. The deadline for 

receipt is October 15, 2018. 

ADDRESSES: CDC, 1600 Clifton Road NE, 

Tom Harkin Global Communications 

Center, Kent ‘Oz’ Nelson Auditorium, 

Atlanta, GA 30329–4027. 

The meeting will be webcast live via 

the World Wide Web; for instructions 

and more information on ACIP please 

visit the ACIP website: http://

www.cdc.gov/vaccines/acip/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, CDC, NCIRD, 

telephone 404–639–8836, email ACIP@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children (VFC) program, 

along with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the Director of the 

Centers for Disease Control and 

Prevention and appear on CDC 

immunization schedules must be 

covered by applicable health plans. 

Matters to Be Considered: The agenda 

will include discussions on child/ 

adolescent immunization schedule, 

adult immunization schedule, human 

papillomavirus vaccines, pneumococcal 

vaccines, Japanese encephalitis 

vaccines, zoster vaccine, Influenza 

vaccines, general recommendations, 

anthrax vaccine, hepatitis A vaccine, 

Pertussis vaccine, and meningococcal 

vaccines. A recommendation vote is 

scheduled for child/adolescent 

immunization schedule and adult 

immunization schedule. Agenda items 

are subject to change as priorities 

dictate. For more information on the 

meeting agenda visit https://

www.cdc.gov/vaccines/acip/meetings/ 

meetings-info.html. 

Public Comment: Written comments 

must include full name, address, 

organizational affiliation, email address 

of the speaker, topic being addressed 

and specific comments. Written 

comments must not exceed one singlespaced typed page with 1-inch margins 

containing all items above. Only those 

written comments received 10 business 

days in advance of the meeting will be 

included in the official record of the 

meeting. Public comments made in 

attendance must be no longer than 3 

minutes and the person giving 

comments must attend the public 

comment session at the start time listed 

on the agenda. Time for public 

comments may start before the time 

indicated on the agenda. The Director, 

Management Analysis and Services 

Office, has been delegated the authority 

to sign Federal Register notices 

pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–18184 Filed 8–22–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–18–18ATK; Docket No.CDC–2018– 

0075] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Understanding multi-sectoral 

collaboration for strengthening public 

health capacities in Ethiopia. The goal 

of this study is to explore multi-sectoral 

collaboration in Ethiopia, in the context 

of strengthening public health capacities 

under the Global Health Security 

Agenda. 

DATES: CDC must receive written 

comments on or before October 22, 

2018. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2018– 

0075 by any of the following methods: 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 164 / Thursday, August 23, 2018 / Notices 42657 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7118; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Understanding multi-sectoral 

collaboration for strengthening public 

health capacities in Ethiopia—New— 

Office of Public Health Preparedness 

and Response (OPHPR), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Countries with poor public health 

infrastructure are more vulnerable to 

adverse health outcomes caused by 

disease outbreaks, natural disasters, and 

other public health events (Rodier, 

2007). The 2013 Ebola outbreak in West 

Africa highlighted the shortcomings of 

infrastructure and preparedness plans in 

the region, and prompted Ministries of 

Health in affected countries to 

reexamine capabilities and identify 

approaches for strengthening them 

(Heymann, 2015). More recently, the 

spread of the Zika virus in 2015 through 

more than twenty countries in the 

Americas demonstrated that prioritizing 

efforts to strengthen public health 

systems and capacities is imperative to 

mitigating the impact of public health 

events and improving global health 

security (Lucey, 2016). 

Capacities refer to the abilities and 

resources of countries to identify and 

address problems, and carry out 

functions for public health. Public 

health emergency preparedness (PHEP) 

related capacities focus acutely on the 

resources and infrastructure required for 

communities and countries to 

effectively respond to incidents. 

Zoonotic disease (ZD) related capacities 

center on minimizing the spread of 

diseases from animals to humans in 

domestic, agricultural and wildlife 

settings. 

PHEP and ZD are regarded as crosscutting technical areas of public health, 

spanning numerous fields of practice 

and knowledge necessary to 

successfully mitigate the impacts of 

public health events. As a result, multisectoral collaboration—a cornerstone of 

many public health initiatives and 

programs—is a prominent feature of 

efforts and plans to strengthen PHEP 

and ZD capacities. While the 

importance of multi-sectoral 

collaboration for health strategies is 

widely recognized by global health 

experts and leaders, the evidence base 

on demonstrated benefits and 

advantages in public health capacity 

building is limited. Some research has 

been carried out to understand aspects 

of public health capacity strengthening 

efforts and their impact on global health 

security; however, it often focuses on 

high-income countries, such as the 

United States (U.S.). More research is 

needed, particularly in low- and 

middle-income country settings, to 

understand how collaboration occurs 

across sectors to implement efforts to 

strengthen PHEP and ZD capacities and 

systems, and to gain a deeper 

understanding of the perspectives of 

partners involved in the collaboration. 

The purpose of the proposed research 

is to explore how multi-sectoral 

collaboration occurs for PHEP and ZD 

related activities implemented under 

the Global Health Security Agenda 

(GHSA). The research will employ a 

multiple-case study design in Ethiopia, 

focusing on the GHSA technical areas of 

PHEP and ZD as the cases. The study 

seeks to understand the landscape of 

stakeholders engaged in PHEP and ZD 

related capacity development, and their 

perspectives on one another’s roles and 

contributions to efforts. This research 

will also examine stakeholder 

perceptions on barriers and facilitators 

to collaboration under GHSA, overall 

and in each technical area via in-depth 

interviews. Finally, this study will 

utilize an adapted questionnaire that 

measures collaboration across five key 

domains to foster dialogue between 

partners on the strength of multisectoral collaboration in Ethiopia for 

GHSA related ZD and PHEP activities. 

Participants will be able to provide 

feedback to these questionnaires 

through a workshop. Research findings 

will be compared across the two 

technical areas to understand 

similarities and differences in 

stakeholder environments and partner 

perspectives on collaboration under 

GHSA; they can also be used to identify 

opportunities to amplify successes and 

overcome challenges for stakeholders to 

collaborate across sectors—in Ethiopia 

and other countries—to achieve ZD and 

PHEP goals under GHSA. CDC will 

disseminate information and findings 

through presentations, publications, and 

summary reports to stakeholders and 

interested members of the public. This 

research can enrich understanding 

among stakeholders of one another’s 

perspectives on collaborative efforts, 

and encourage further dialogue on how 

to best facilitate multi-sectoral 

collaboration for broad global agendas 

such as GHSA, and improved health 

outcomes overall. CDC is requesting a 

two year approval for this information 

collection. Information collection 

activities will begin approximately one 

month after OMB approval. 


daltland on DSKBBV9HB2PROD with NOTICES
42658 Federal Register / Vol. 83, No. 164 / Thursday, August 23, 2018 / Notices 

The total estimated cost to 

respondents for their participation in 

this proposed information collection is 

$12,483.20. The total estimated burden 

to respondents is 320 hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Emergency Management Directors ... In-depth interviews ........................... 80 1 1 80 

Emergency Management Directors ... Questionnaire ................................... 80 1 1 80 

Emergency Management Directors ... Questionnaire Feedback .................. 40 1 4 160 

Total ........................................... .......................................................... ........................ ........................ ........................ 320 

Jeffrey M. Zirger, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–18179 Filed 8–22–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the Board of Scientific 

Counselors (BSC), Office of Infectious 

Diseases (OID) 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) is seeking 

nominations for membership on the 

BSC, OID. The BSC, OID, consists of 17 

experts in fields associated with the 

issues addressed by CDC’s infectious 

disease national centers (e.g., respiratory 

diseases, antimicrobial resistance, 

foodborne diseases, zoonotic and 

vectorborne diseases, sexually 

transmitted diseases) and specialties, 

including clinical and public health 

practice (including state and local 

health departments), research and 

diagnostics, bioinformatics, health 

policy/communications, and industry. 

Nominations are being sought for 

individuals who have expertise and 

qualifications necessary to contribute to 

the accomplishments of the committee’s 

objectives. Nominees will be selected 

based on expertise in the fields of 

infectious diseases and related 

specialties. Federal employees will not 

be considered for membership. 

Members may be invited to serve for up 

to four-year terms. 

Selection of members is based on 

candidates’ qualifications to contribute 

to the accomplishment of BSC, OID, 

objectives (www.cdc.gov/oid/BSC.html). 

DATES: Nominations for membership on 

the BSC, OID, must be received no later 

than October 31, 2018. Packages 

received after this time will not be 

considered for the current membership 

cycle. 

ADDRESSES: All nominations should be 

mailed to BSC, OID, MS H–24–12, 1600 

Clifton Road, Atlanta, GA 30329, or 

emailed (recommended) to SWiley@

cdc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Sarah Wiley, M.P.H., Senior Advisor, 

Office of Infectious Diseases, CDC, MS 

H–24–12, 1600 Clifton Road, Atlanta, 

GA 30329, 404–639–2100, SWiley@

cdc.gov. 

SUPPLEMENTARY INFORMATION: The U.S. 

Department of Health and Human 

Services policy stipulates that 

committee membership be balanced in 

terms of points of view represented and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens, 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on federal workgroups or 

prior experience serving on a federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. Committee 

members are Special Government 

Employees (SGEs), requiring the filing 

of financial disclosure reports at the 

beginning and annually during their 

terms. CDC reviews potential candidates 

for BSC, OID membership each year, 

and provides a slate of nominees for 

consideration to the Secretary of HHS 

for final selection. HHS notifies selected 

candidates of their appointment near 

the start of the term in October 2019, or 

as soon as the HHS selection process is 

completed. Note that the need for 

different expertise varies from year to 

year and a candidate who is not selected 

in one year may be reconsidered in a 

subsequent year. SGE Nominees must be 

U.S. citizens, and cannot be full-time 

employees of the U.S. Government. 

Candidates should submit the following 

items: 

D Current curriculum vitae, including 

complete contact information 

(telephone numbers, mailing address, 

email address). 

D At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. 

(Candidates may submit letter(s) from 

current HHS employees if they wish, 

but at least one letter must be submitted 

by a person not employed by an HHS 

agency (e.g., CDC, NIH, FDA, etc.). 

Nominations may be submitted by the 

candidate him- or herself, or by the 

person/organization recommending the 

candidate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both CDC and 

the Agency for Toxic Substances and 

Disease Registry. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–18187 Filed 8–22–18; 8:45 am] 

BILLING CODE 4163–18–P 


daltland on DSKBBV9HB2PROD with NOTICES